A citation-based method for searching scientific literature

So Miyahara, Makoto Hamasaki, Daisuke Hamatake, Shin-Ichi Yamashita, Takeshi Shiraishi, Akinori Iwasaki, Kazuki Nabeshima. Lung Cancer 2015
Times Cited: 15







List of co-cited articles
55 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.
Takahiro Mochizuki, Genichiro Ishii, Kanji Nagai, Junji Yoshida, Mitsuyo Nishimura, Tetsuya Mizuno, Tomoyuki Yokose, Kazuya Suzuki, Atsushi Ochiai. Am J Surg Pathol 2008
133
33

Pleomorphic carcinoma of the lung: a surgical outcome.
Tsuyoshi Yuki, Toshiko Sakuma, Chiho Ohbayashi, Masahiro Yoshimura, Noriaki Tsubota, Yutaka Okita, Morihito Okada. J Thorac Cardiovasc Surg 2007
82
26

Clinicopathological characteristics of surgically resected pulmonary pleomorphic carcinoma.
Fengshi Chen, Makoto Sonobe, Toshihiko Sato, Hiroaki Sakai, Cheng-Long Huang, Toru Bando, Hiroshi Date. Eur J Cardiothorac Surg 2012
15
26

Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.
Yongqing Liu, Xiaoqin Lu, Li Huang, Wei Wang, Guomin Jiang, Kevin C Dean, Brian Clem, Sucheta Telang, Alfred B Jenson, Miriam Cuatrecasas,[...]. Nat Commun 2014
45
20



Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
Jin-Yuan Shih, Meng-Feng Tsai, Tzu-Hua Chang, Yih-Leong Chang, Ang Yuan, Chong-Jen Yu, Shin-Bey Lin, Geou-Yarh Liou, Meng-Larn Lee, Jeremy J W Chen,[...]. Clin Cancer Res 2005
184
20

The basics of epithelial-mesenchymal transition.
Raghu Kalluri, Robert A Weinberg. J Clin Invest 2009
20

Clinical characteristics of pleomorphic carcinoma of the lung.
Kenichiro Ito, Satoshi Oizumi, Shinichi Fukumoto, Masao Harada, Takashi Ishida, Yuka Fujita, Toshiyuki Harada, Tetsuya Kojima, Hiroshi Yokouchi, Masaharu Nishimura. Lung Cancer 2010
80
20


Clinicopathological investigation of pulmonary pleomorphic carcinoma.
Satoshi Yamamoto, Daisuke Hamatake, Takao Ueno, Takao Higuchi, Masahumi Hiratsuka, Takeshi Shiraishi, Akinori Iwasaki, Takayuki Shirakusa. Eur J Cardiothorac Surg 2007
26
20

Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
Kyoichi Kaira, Yoshiki Horie, Eriko Ayabe, Haruyasu Murakami, Toshiaki Takahashi, Asuka Tsuya, Yukiko Nakamura, Tateaki Naito, Masahiro Endo, Haruhiko Kondo,[...]. J Thorac Oncol 2010
73
20

Personal experience in surgical management of pulmonary pleomorphic carcinoma.
Federico Raveglia, Maurizio Mezzetti, Tiziana Panigalli, Simone Furia, Luigi Giuliani, Serena Conforti, Stefano Meda. Ann Thorac Surg 2004
82
20

Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Hyun-Mi Bae, Hye Sook Min, Se-Hoon Lee, Dong-Wan Kim, Doo Hyun Chung, Jong-Seok Lee, Young Whan Kim, Dae Seog Heo. Lung Cancer 2007
109
20

The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
Jung Yong Hong, Moon Ki Choi, Ji Eun Uhm, Min Jae Park, Jeeyun Lee, Yeon Hee Park, Jin Seok Ahn, Keunchil Park, Joung Ho Han, Myung Ju Ahn. Med Oncol 2009
44
13

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
K Aigner, B Dampier, L Descovich, M Mikula, A Sultan, M Schreiber, W Mikulits, T Brabletz, D Strand, P Obrist,[...]. Oncogene 2007
451
13

ZEB1 in Pancreatic Cancer.
Ulrich Wellner, Thomas Brabletz, Tobias Keck. Cancers (Basel) 2010
38
13

Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2012
13

A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.
Anurag Singh, Patricia Greninger, Daniel Rhodes, Louise Koopman, Sheila Violette, Nabeel Bardeesy, Jeff Settleman. Cancer Cell 2009
606
13

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Samir E Witta, Robert M Gemmill, Fred R Hirsch, Christopher D Coldren, Karla Hedman, Larisa Ravdel, Barbara Helfrich, Rafal Dziadziuszko, Daniel C Chan, Michio Sugita,[...]. Cancer Res 2006
411
13


The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Kerstin Mock, Bogdan-Tiberius Preca, Tilman Brummer, Simone Brabletz, Marc P Stemmler, Thomas Brabletz. Oncotarget 2015
38
13


Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.
Christine L Chaffer, Nemanja D Marjanovic, Tony Lee, George Bell, Celina G Kleer, Ferenc Reinhardt, Ana C D'Alessio, Richard A Young, Robert A Weinberg. Cell 2013
593
13

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.
Tzu-Hua Chang, Meng-Feng Tsai, Kang-Yi Su, Shang-Gin Wu, Cheng-Po Huang, Sung-Liang Yu, Yung-Luen Yu, Chou-Chin Lan, Chih-Hsin Yang, Shwu-Bin Lin,[...]. Am J Respir Crit Care Med 2011
132
13

MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Jin Hao, Yueling Zhang, Mengzhao Deng, Rui Ye, Sen Zhao, Yating Wang, Juan Li, Zhihe Zhao. Int J Cancer 2014
53
13

Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.
Yoshimi Arima, Hidemi Hayashi, Mikako Sasaki, Mari Hosonaga, Takaaki M Goto, Tatsuyuki Chiyoda, Shinji Kuninaka, Tatsuhiro Shibata, Hirokazu Ohata, Hitoshi Nakagama,[...]. J Biol Chem 2012
60
13

A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
Guanghui Wang, Wei Dong, Hongchang Shen, Xueru Mu, Zhenxiang Li, Xiaoyan Lin, Ying Liu, Jiajun Du. Eur J Cardiothorac Surg 2011
42
13

Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.
Chie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, Yutaka Kawakami. Cancer Cell 2009
584
13

EMT and dissemination precede pancreatic tumor formation.
Andrew D Rhim, Emily T Mirek, Nicole M Aiello, Anirban Maitra, Jennifer M Bailey, Florencia McAllister, Maximilian Reichert, Gregory L Beatty, Anil K Rustgi, Robert H Vonderheide,[...]. Cell 2012
13

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.
Cameron P Bracken, Philip A Gregory, Natasha Kolesnikoff, Andrew G Bert, Jun Wang, M Frances Shannon, Gregory J Goodall. Cancer Res 2008
818
13

The role of the ZEB family of transcription factors in development and disease.
C Vandewalle, F Van Roy, G Berx. Cell Mol Life Sci 2009
343
13

Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Kyoichi Kaira, Masahiro Endo, Masato Abe, Kazuo Nakagawa, Yasuhisa Ohde, Takehiro Okumura, Toshiaki Takahashi, Haruyasu Murakami, Asuka Tsuya, Yukiko Nakamura,[...]. Lung Cancer 2011
31
13

Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases.
N F Fishback, W D Travis, C A Moran, D G Guinee, W F McCarthy, M N Koss. Cancer 1994
211
13

Epithelial-mesenchymal transition and its implications for fibrosis.
Raghu Kalluri, Eric G Neilson. J Clin Invest 2003
13

Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer.
Masayoshi Toge, Satoru Yokoyama, Shinichiro Kato, Hiroaki Sakurai, Kazutaka Senda, Yoshinori Doki, Yoshihiro Hayakawa, Naoki Yoshimura, Ikuo Saiki. Int J Oncol 2015
30
13

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Miso Kim, Tae Min Kim, Jin-Ho Kim, Yoon Kyung Jeon, Ju-Seog Lee, Seong Keun Kwon, J Hun Hah,[...]. Oncotarget 2016
105
13

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
Kari R Fischer, Anna Durrans, Sharrell Lee, Jianting Sheng, Fuhai Li, Stephen T C Wong, Hyejin Choi, Tina El Rayes, Seongho Ryu, Juliane Troeger,[...]. Nature 2015
13

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
Yanyan Lou, Lixia Diao, Edwin Roger Parra Cuentas, Warren L Denning, Limo Chen, You Hong Fan, Lauren A Byers, Jing Wang, Vassiliki A Papadimitrakopoulou, Carmen Behrens,[...]. Clin Cancer Res 2016
276
13

Biomarkers for epithelial-mesenchymal transitions.
Michael Zeisberg, Eric G Neilson. J Clin Invest 2009
13

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Lecia V Sequist, Belinda A Waltman, Dora Dias-Santagata, Subba Digumarthy, Alexa B Turke, Panos Fidias, Kristin Bergethon, Alice T Shaw, Scott Gettinger, Arjola K Cosper,[...]. Sci Transl Med 2011
13

Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.
Lu Xie, Brian K Law, Anna M Chytil, Kimberly A Brown, Mary E Aakre, Harold L Moses. Neoplasia 2004
377
13

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
Lauren Averett Byers, Lixia Diao, Jing Wang, Pierre Saintigny, Luc Girard, Michael Peyton, Li Shen, Youhong Fan, Uma Giri, Praveen K Tumula,[...]. Clin Cancer Res 2013
663
13

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Limo Chen, Don L Gibbons, Sangeeta Goswami, Maria Angelica Cortez, Young-Ho Ahn, Lauren A Byers, Xuejun Zhang, Xiaohui Yi, David Dwyer, Wei Lin,[...]. Nat Commun 2014
608
13

Hedgehog signalling in prostate regeneration, neoplasia and metastasis.
Sunil S Karhadkar, G Steven Bova, Nadia Abdallah, Surajit Dhara, Dale Gardner, Anirban Maitra, John T Isaacs, David M Berman, Philip A Beachy. Nature 2004
827
13

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.
Jin Kyung Rho, Yun Jung Choi, Jin Kyung Lee, Baek-Yeol Ryoo, Im Il Na, Sung Hyun Yang, Cheol Hyeon Kim, Jae Cheol Lee. Lung Cancer 2009
180
13

Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis.
Sai Yendamuri, Laura Caty, Marybeth Pine, Soumya Adem, Paul Bogner, Austin Miller, Todd L Demmy, Adrienne Groman, Mary Reid. Surgery 2012
131
13

Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.
Thibault Vieira, Nicolas Girard, Mony Ung, Isabelle Monnet, Aurélie Cazes, Pierre Bonnette, Michael Duruisseaux, Julien Mazieres, Martine Antoine, Jacques Cadranel,[...]. J Thorac Oncol 2013
121
13

Clinicoradiological outcomes of 33 cases of surgically resected pulmonary pleomorphic carcinoma: correlation with prognostic indicators.
Akifumi Nishida, Hajime Abiru, Hideyuki Hayashi, Masataka Uetani, Keitaro Matsumoto, Tomoshi Tsuchiya, Naoya Yamasaki, Takeshi Nagayasu, Tomayoshi Hayashi, Naoe Kinoshita,[...]. Eur Radiol 2016
7
28

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.